Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
| ▸ | METAP2 | P50579 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17444071 | 0.81 | ACHE (0.41) | ACHERAB9ANPC1HPGDTSHR | |
| SCHEMBL7873510 | 0.81 | ESR2 (0.46) | CYP1A2IDO1ALDH1A1KMT2AMEN1 | |
| SCHEMBL7004734 | 0.81 | AKR1C2 (0.39) | ACHERAB9ANPC1HPGDTSHR | |
| SCHEMBL2012944 | 0.81 | MGAM (0.42) | ACHENOTUMIDO1 | |
| SCHEMBL16720373 | 0.81 | ACHE (0.41) | ACHECYP1A2RAB9AL3MBTL1 | |
| SCHEMBL981110 | 0.79 | TSHR (0.39) | ACHECYP2A6RAB9ANPC1HPGD | |
| SCHEMBL7843209 | 0.79 | DYRK1A (0.45) | ACHECYP1A2CYP2A6NOTUMALDH1A1 | |
| SCHEMBL8093284 | 0.79 | HPGD (0.43) | ACHERAB9ANPC1HPGDTSHR | |
| SCHEMBL3346134 | 0.78 | ACHE (0.35) | ACHECYP1A2CYP2A6RAB9ANPC1 | |
| SCHEMBL15949380 | 0.78 | IKBKB (0.41) | CYP1A2RAB9ANPC1HPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4008715-B1 | HALOGEN SUBSTITUTED COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | KEYLAB JIANGSU TECH CO LTD (CN) | 2024-03-06 | — | — | EP | disclosed |
| EP-4008715-A1 | HALOGEN SUBSTITUTED COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Suqian Keylab Biochemical Co., Ltd. (CN) | 2022-06-08 | — | — | EP | disclosed |
| EP-2407514-B1 | REINFORCED POLYESTER RESIN COMPOSITION | ADEKA CORP (JP) | 2017-03-01 | — | — | EP | disclosed |
| US-20150328588-A1 | FILTRATION SYSTEMS AND MEMBRANES WITH ENHANCED FLUX AND METHOD FOR THEIR PREPARATION | BASF SE (DE) | 2015-11-19 | — | — | US | disclosed |
| US-20150274891-A1 | MEMBRANES WITH IMPROVED FLUX AND METHOD FOR THEIR PREPARATION | BASF SE (DE) | 2015-10-01 | — | — | US | disclosed |
| US-20150252005-A1 | Method of Synthesizing Organic Molecules | VTU HOLDING GMBH (AT) | 2015-09-10 | — | — | US | disclosed |
| US-9018383-B2 | Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals | SANOFI (FR) | 2015-04-28 | — | — | US | disclosed |
| US-9005450-B2 | Use of magnetic, ionic liquids as an extraction agent | PROIONIC PRODUCTION OF IONIC SUBSTANCES GMBH & CO KG (AT) | 2015-04-14 | — | — | US | disclosed |
| EP-2077298-B1 | POLYESTER RESIN COMPOSITION | ADEKA CORP (JP) | 2014-09-24 | — | — | EP | disclosed |
| US-8829084-B2 | Reinforced polyester resin composition | ADEKA CORPORATION (JP) | 2014-09-09 | — | — | US | disclosed |
| US-7605297-B2 | Method for extracting impurities using ionic liquids | BASF AKTIENGESELLSCHAFT (DE) | 2009-10-20 | — | — | US | disclosed |
| US-20090176913-A1 | POLYESTER RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2009-07-09 | — | — | US | disclosed |
| EP-2077298-A1 | POLYESTER RESIN COMPOSITION | Adeka Corporation (JP) | 2009-07-08 | — | — | EP | disclosed |
| US-7501522-B2 | Method for the production of purified 1,3-substituted imidazolium salts | BASF AKTIENGESELLSCHAFT (DE) | 2009-03-10 | — | — | US | disclosed |
| EP-2022826-A1 | POLYESTER RESIN COMPOSITION | Adeka Corporation (JP) | 2009-02-11 | — | — | EP | disclosed |
| US-20080009633-A1 | Method for Producing High-Purity Quaternary Ammonium Compounds | BASF AKTIENGESELLSCHAFT (DE) | 2008-01-10 | — | — | US | disclosed |
| US-20070213374-A1 | Malonamide Derivatives | MERCK PATENT GMBH (DE) | 2007-09-13 | — | — | US | disclosed |
| US-20060149074-A1 | Method for the production of purified 1,3-substituted imidazolium salts | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-06 | — | — | US | disclosed |
| US-7053244-B2 | Method for the continuous production of tetra-substituted ureas | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-30 | — | — | US | disclosed |
| US-20050261524-A1 | Method for the continuous production of tetra-substituted ureas | BASF AKTIENGESELLSCHAFT (DE) | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060149074-A1 | Method for the production of purified 1,3-substituted imidazolium salts | HIRA, HAO2, HACL2 | ACHE 4864/4885CYP1A2 3187/4885CYP2A6 2558/4885 |
| US-20150252005-A1 | Method of Synthesizing Organic Molecules | ICMT, DNMT3A, DNMT1 | ACHE 666/4885CYP1A2 292/4885CYP2A6 206/4885 |
| US-20050261524-A1 | Method for the continuous production of tetra-substituted ureas | UGP2, UTS2R, UMPS | ACHE 1309/4885CYP1A2 947/4885CYP2A6 2244/4885 |
| US-20080009633-A1 | Method for Producing High-Purity Quaternary Ammonium Compounds | SP1, EIF3A, EIF3H | ACHE 4475/4885CYP1A2 4706/4885CYP2A6 4710/4885 |
| US-20070213374-A1 | Malonamide Derivatives | RAF1, BRAF, ARAF | ACHE 4071/4885CYP1A2 1089/4885CYP2A6 1187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.